Merus’ $460m Upsized Follow-On Offering of Common Shares

Latham & Watkins and NautaDutilh advised Merus on the offering.Merus N.V., an oncology company in the clinical stage, successfully raised an estimated USD 460 million in…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Georgio Naffaa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here